February 29, 2024MMWR Morbidity and Mortality Weekly ReportOpen Access

Interim Estimates of 2023–24 Seasonal Influenza Vaccine Effectiveness — United States

View Full Paper

Ask AI

Bookmark

The seasonal influenza vaccine significantly reduced medical visits, providing 59% to 67% effectiveness against outpatient encounters in children and adolescents.
Test-negative case-control study methodology evaluated patients with acute respiratory illness across four clinical networks to quantify protection against influenza A and B.
Supports current CDC recommendations for annual influenza vaccine uptake among persons aged six months and older, highlighting continued protection against severe clinical infection.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Test-negative case-control study demonstrates substantial vaccine effectiveness in pediatric and adult patients, highlighting the broad protective benefit of annual vaccination.

Cite This Study

Frutos et al. (2024) studied this question.

synapsesocial.com/papers/68e76cedb6db6435876e27e5 https://doi.org/10.15585/mmwr.mm7308a3

View Full Paper

Ask AI

Bookmark

Implication

Test-negative case-control study demonstrates substantial vaccine effectiveness in pediatric and adult patients, highlighting the broad protective benefit of annual vaccination.

Interim Estimates of 2023–24 Seasonal Influenza Vaccine Effectiveness — United States

Key Points

Discussion

Implication

Cite This Study

Interim Estimates of 2023–24 Seasonal Influenza Vaccine Effectiveness — United States

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider